Sterile Products Collaborative

The Pharmacy Enterprise Sterile Products Collaborative is responsible for maintaining compliance in both USP 797 and USP 800 federal regulations which govern compounding of all sterile products.

Membership

Chair: Sterile Products Supervisor, RWJBarnabas Health Infusion and Specialty Pharmacy Services
Members: Vice President of RWJBarnabas Health Infusion and Specialty Pharmacy Services, Director of Pharmacy RWJBarnabas Health Infusion and Specialty Pharmacy Services, Corporate Director of Pharmacy Operations, Chief Oncology Pharmacist, Sterile Products / IV Room Supervisors from the Acute Care Service Line, Executive Director of Oncology Pharmacy Services and Research Pharmacy Shared Resource Rutgers Cancer Institute of New Jersey

Duties and Responsibilities

• Renovating all clean rooms and areas where sterile compounding takes place in each facility to meet new USP 797 and 800 regulations
• Standardizing the maintenance of clean rooms, including the equipment and cleaning products used
• Standardizing the competency of employees that will work in the compounding of sterile products
• Standardization of policies for compounding, cleaning, and maintenance of the clean rooms or areas
• Guide decisions on what products to centralize the compounding at RWJBarnabas Health Infusion and Specialty Pharmacy Services Pharmacy Services

Sterile Products Collaborative Membership